Baxter Minicap dialysis injuries include peritonitis, a dangerous blood infection that can lead to organ failure and death.  In January 2015, the manufacturer of Baxter Minicap dialysis products notified healthcare providers and consumers of these problems.  The warnings stated that:

Baxter received complaints indicating that the sponge of the MiniCap was fully separated from the cap, partially protruding from the cap, or missing.

Use of MiniCaps with sponges fully separated or missing from the caps may compromise the ability of the MiniCap to provide a sterile barrier protection at the end of the transfer set when the transfer set is not connected to the patient line of the automated peritoneal dialysis (APD) cassette or continuous ambulatory peritoneal dialysis (CAPD) twin bag set-ups. This may increase the risk of peritonitis.

Use of the MiniCaps with sponges protruding from the caps may encourage non-aseptic techniques, such as inadvertently touching the sponge to reposition it inside the cap. This may increase the risk of peritonitis.

Two months later, the United States Food & Drug Administration (FDA) issued a Class 2 recall of the affected Baxter Minicap dialysis products.

Clark Perdue has filed a lawsuit in the United States District Court, Southern District of Ohio, for injuries and death resulting from use of a defective Baxter Minicap dialysis product.  The lawsuit alleges that a woman used the defective Baxter MiniCap dialysis products in the late summer and early fall of 2014.   Her conditioned deteriorated over a period of months, until she was ultimately diagnosed with septic shock due to peritonitis.   Unfortunately, she passed away before the FDA recall, and before notice was given to healthcare providers and consumers of the problems associated with the defective Baxter Minicap dialysis products.

Please contact us if you would like further information regarding defective Baxter Minicap dialysis products.